Biotech Growth Trust (The) (LSE:BIOG) Scaled Net Operating Assets : 1.32 (As of Mar. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Biotech Growth Trust (The) Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Biotech Growth Trust (The)'s operating assets for the quarter that ended in Mar. 2024 was £409.29 Mil. Biotech Growth Trust (The)'s operating liabilities for the quarter that ended in Mar. 2024 was £3.04 Mil. Biotech Growth Trust (The)'s Total Assets for the quarter that ended in Sep. 2023 was £308.21 Mil. Therefore, Biotech Growth Trust (The)'s scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 1.32.

Biotech Growth Trust (The) Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Biotech Growth Trust (The)'s Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Mar. 2024 )
=	(Operating Assets (A: Mar. 2024 )	-	Operating Liabilities (A: Mar. 2024 ))	/	Total Assets (A: Mar. 2023 )
=	(409.289	-	3.035)	/	360.509
=	1.13

where

	Operating Assets		(A: Mar. 2024 )
=	Total Assets	-	Balance Sheet Cash And Cash Equivalents
=	411.42	-	2.131
=	409.289

	Operating Liabilities		(A: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	50.113	-	47.078	-	0
=	3.035

Biotech Growth Trust (The)'s Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Sep. 2023 )
=	(409.289	-	3.035)	/	308.211
=	1.32

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Balance Sheet Cash And Cash Equivalents
=	411.42	-	2.131
=	409.289

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	50.113	-	47.078	-	0
=	3.035

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotech Growth Trust (The) Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Biotech Growth Trust (The)'s Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotech Growth Trust (The) (LSE:BIOG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Biotech Growth Trust (The) PLC (LSE:BIOG) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

BIOGl:UK

Address

25 Southampton Buildings, London, GBR, WC2A 1AL

Website

https://www.biotechgt.com

Biotech Growth Trust (The) PLC is a United Kingdom-based investment trust. Its business objective is to provide its investors with capital appreciation by investing in the biotechnology industry around the world. The company portfolio comprises emerging biotechnology companies across North America, Europe, and Asia, of which North America accounts for the investment share.